Navigation Links
Leading Asbestos-Cancer Group Urges Congress to Partner with Them and Support Funding Provisions in Asbestos Ban Legislation
Date:2/28/2008

- The following statement was issued by The Mesothelioma Applied Research Foundation (Meso Foundation) to coincide with hearings held by the House Energy and Commerce Committee on the "Bruce Vento Ban Asbestos and Prevent Mesothelioma Act"(HR 3339), today, Thursday, February 28, 2008. The Meso Foundation is urging the House of Representatives to move expeditiously and step-up to the plate in allocating research funds for mesothelioma and

partner with the Meso Foundation in developing effective medical

treatments. -

WASHINGTON, Feb. 28 /PRNewswire-USNewswire/ -- The Mesothelioma Applied Research Foundation (Meso Foundation) is urging Members of Congress to pass Representative Betty L. McCollum's (D-Minnesota) "Bruce Vento Ban Asbestos and Prevent Mesothelioma Act" (HR 3339) and work with the Senate to get a bill to the President's desk for his signature during this Congressional session.

Today at 12:30 PM EST the House Energy and Commerce Committee will hold a hearing on HR 3339. This is the companion legislation to Senator Patricia Lynn Murray's (D-Minnesota) legislation in the U.S. Senate. The Act is dedicated to late Congressman Bruce Vento, who succumbed to mesothelioma in 2000. (Due to the length of the URL link, please copy and paste into a browser window for the audio webcast: http://energycommerce.edgeboss.net/wmedia- live/energycommerce/11991/100_energycommerce-2322_060901.asx )

Last October, the U.S. Senate unanimously passed Senator Murray's Ban Asbestos in America Act, which prohibits asbestos where present at more than 1% by weight, calls for a public education campaign about the dangers of asbestos exposure, and directs critically-needed federal research to begin to develop treatments for mesothelioma and other asbestos-related diseases.

For decades, asbestos was used heavily in Navy ships and shipyards;
'/>"/>

SOURCE The Mesothelioma Applied Research Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Crdentia Selected by Leading Staffing Vendor to Provide Health Care Staffing Services to One of the Largest Hospital Chains in the U.S.
2. DuPont Strengthens Leading Biotechnology Position with Leadership Changes
3. Americas StriVectin the Only Great Serum for Mature, Aging Complexions, Says Leading British Newspaper
4. XCPT(TM) Patient Engagement and Communication Software and DentalXP.com, a Leading Provider of Online Dental Education and Content, Sign a Co-Marketing Agreement
5. Sigma-Aldrich Licenses From NeuroSurvival Technologies a Leading Marker for Molecular Imaging of Apoptosis in Vivo
6. PayFlex Partners With Leading Health Education Company
7. Dr. Welsh Self-Test Diagnoses Glaucoma, the Leading Cause of Preventable- Blindness
8. Leading National Patient Advocacy Group Delivers Warning to U.S. Patients: Having Health Insurance Does NOT Mean Your Medical Needs Will Be Covered
9. Kaiser Permanente Recognized With Leading Awards for The Amazing Food Detective Online Video Game
10. Leading Travel Insurance Website Now Offers Mexican Auto Insurance to US and Canadian Travelers Going into Mexico
11. The Leading Hotels of the World Recreates Film Fantasy in Uber-Luxury Trip: Around The World in 80 Ways
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6HCA Reports Second Quarter 2009 Results 53037 1HCA Reports Second Quarter 2009 Results 53037 2HCA Reports Second Quarter 2009 Results 53037 3HCA Reports Second Quarter 2009 Results 53037 4HCA Reports Second Quarter 2009 Results 53037 5HCA Reports Second Quarter 2009 Results 53037 6HCA Reports Second Quarter 2009 Results 53037 7HCA Reports Second Quarter 2009 Results 53037 8HCA Reports Second Quarter 2009 Results 53037 9HCA Reports Second Quarter 2009 Results 53037 10HCA Reports Second Quarter 2009 Results 53037 11HCA Reports Second Quarter 2009 Results 53037 12HCA Reports Second Quarter 2009 Results 53037 13HCA Reports Second Quarter 2009 Results 53037 14Sanofi aventis Announces Second Quarter 2009 Results 13244 1Sanofi aventis Announces Second Quarter 2009 Results 13244 2Sanofi aventis Announces Second Quarter 2009 Results 13244 3Sanofi aventis Announces Second Quarter 2009 Results 13244 4Sanofi aventis Announces Second Quarter 2009 Results 13244 5Sanofi aventis Announces Second Quarter 2009 Results 13244 6Sanofi aventis Announces Second Quarter 2009 Results 13244 7Sanofi aventis Announces Second Quarter 2009 Results 13244 8Sanofi aventis Announces Second Quarter 2009 Results 13244 9Sanofi aventis Announces Second Quarter 2009 Results 13244 10Sanofi aventis Announces Second Quarter 2009 Results 13244 11Sanofi aventis Announces Second Quarter 2009 Results 13244 12Sanofi aventis Announces Second Quarter 2009 Results 13244 13Sanofi aventis Announces Second Quarter 2009 Results 13244 14Sanofi aventis Announces Second Quarter 2009 Results 13244 15Sanofi aventis Announces Second Quarter 2009 Results 13244 16Sanofi aventis Announces Second Quarter 2009 Results 13244 17Sanofi aventis Announces Second Quarter 2009 Results 13244 18Sanofi aventis Announces Second Quarter 2009 Results 13244 19Sanofi aventis Announces Second Quarter 2009 Results 13244 20Sanofi aventis Announces Second Quarter 2009 Results 13244 21Sanofi aventis Announces Second Quarter 2009 Results 13244 22Sanofi aventis Announces Second Quarter 2009 Results 13244 23Sanofi aventis Announces Second Quarter 2009 Results 13244 24Sanofi aventis Announces Second Quarter 2009 Results 13244 25Sanofi aventis Announces Second Quarter 2009 Results 13244 26Sanofi aventis Announces Second Quarter 2009 Results 13244 27GCP Helpdesk 3A Launch Announcement of gcphelpdesk com 53032 1